Melindo, Emmalyn A.
HRN: 22-32-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CEFUROXIME 1.5GM (VIAL)
01/09/2023
01/16/2023
IV
1.5GMS
Q8h
S/P LTCS, MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes